Cyclic ADP-ribose

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 463282

CAS#: 119340-53-3

Description: Cyclic ADP-ribose is a pyridine nucleotide that mobilizes calcium. It is synthesized from nicotinamide adenine dinucleotide (NAD) by ADP RIBOSE CYCLASE.


Chemical Structure

img
Cyclic ADP-ribose
CAS# 119340-53-3

Theoretical Analysis

MedKoo Cat#: 463282
Name: Cyclic ADP-ribose
CAS#: 119340-53-3
Chemical Formula: C15H21N5O13P2
Exact Mass: 541.06
Molecular Weight: 541.303
Elemental Analysis: C, 33.28; H, 3.91; N, 12.94; O, 38.42; P, 11.44

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Cyclic ADP-ribose; Cyclic ADP ribose; cADPR; cAPD ribose; E-NAD; ENAD; E NAD; Enzyme-activated NAD; Enzyme activated NAD;

IUPAC/Chemical Name: Adenosine 5'-(trihydrogen diphosphate), N-alpha-D-ribofuranosyl-, intramol. 5'-5'-ester

InChi Key: BQOHYSXSASDCEA-KEOHHSTQSA-N

InChi Code: InChI=1S/C15H21N5O13P2/c16-12-7-13-18-4-19(12)14-10(23)8(21)5(31-14)1-29-34(25,26)33-35(27,28)30-2-6-9(22)11(24)15(32-6)20(13)3-17-7/h3-6,8-11,14-16,21-24H,1-2H2,(H,25,26)(H,27,28)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1

SMILES Code: O=P(OP(O)(OC[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O1)=O)(O)OC[C@H]3O[C@@H]([N@@](C=N4)C5=C4C([N@]2C=N5)=N)[C@H](O)[C@@H]3O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 541.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Chiba Y, Matsumoto M, Hanazaki M, Sakai H. Downregulation of miR-140-3p Contributes to Upregulation of CD38 Protein in Bronchial Smooth Muscle Cells. Int J Mol Sci. 2020 Oct 27;21(21):E7982. doi: 10.3390/ijms21217982. PMID: 33121100.

2: Evans AM. On a Magical Mystery Tour with 8-Bromo-Cyclic ADP-Ribose: From All- or-None Block to Nanojunctions and the Cell-Wide Web. Molecules. 2020 Oct 16;25(20):4768. doi: 10.3390/molecules25204768. PMID: 33081414; PMCID: PMC7587525.

3: Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020 Oct 7;5(1):227. doi: 10.1038/s41392-020-00311-7. PMID: 33028824; PMCID: PMC7539288.

4: Omer A, Barrera MC, Moran JL, Lian XJ, Di Marco S, Beausejour C, Gallouzi IE. G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat Commun. 2020 Oct 5;11(1):4979. doi: 10.1038/s41467-020-18734-9. PMID: 33020468; PMCID: PMC7536198.

5: Virdi RS, Bavisotto RV, Hopper NC, Vuksanovic N, Melkonian TR, Silvaggi NR, Frick DN. Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3. SLAS Discov. 2020 Sep 28:2472555220960428. doi: 10.1177/2472555220960428. Epub ahead of print. PMID: 32981460.

6: Fliegert R, Riekehr WM, Guse AH. Does Cyclic ADP-Ribose (cADPR) Activate the Non-selective Cation Channel TRPM2? Front Immunol. 2020 Aug 11;11:2018. doi: 10.3389/fimmu.2020.02018. PMID: 32903769; PMCID: PMC7438885.

7: Xu W, Li L, Zhang L. NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death. Front Physiol. 2020 Aug 13;11:901. doi: 10.3389/fphys.2020.00901. PMID: 32903597; PMCID: PMC7438569.

8: Kang BE, Choi JY, Stein S, Ryu D. Implications of NAD+ boosters in translational medicine. Eur J Clin Invest. 2020 Oct;50(10):e13334. doi: 10.1111/eci.13334. Epub 2020 Jul 22. PMID: 32594513.

9: Gerasimenko M, Cherepanov SM, Furuhara K, Lopatina O, Salmina AB, Shabalova AA, Tsuji C, Yokoyama S, Ishihara K, Brenner C, Higashida H. Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder. Sci Rep. 2020 Jun 22;10(1):10035. doi: 10.1038/s41598-019-57236-7. PMID: 32572044; PMCID: PMC7308284.

10: Kincaid JW, Berger NA. NAD metabolism in aging and cancer. Exp Biol Med (Maywood). 2020 Nov;245(17):1594-1614. doi: 10.1177/1535370220929287. Epub 2020 Jun 5. PMID: 32500741.

11: Guedes AG, Dileepan M, Jude JA, Deshpande DA, Walseth TF, Kannan MS. Role of CD38/cADPR signaling in obstructive pulmonary diseases. Curr Opin Pharmacol. 2020 Apr;51:29-33. doi: 10.1016/j.coph.2020.04.007. Epub 2020 May 29. PMID: 32480246; PMCID: PMC7529733.

12: Li JP, Wei W, Li XX, Xu M. Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca2+ release in vascular smooth muscle cells in diabetic mice. Life Sci. 2020 Aug 15;255:117758. doi: 10.1016/j.lfs.2020.117758. Epub 2020 May 11. PMID: 32407845.

13: Tolomeo S, Chiao B, Lei Z, Chew SH, Ebstein RP. A Novel Role of CD38 and Oxytocin as Tandem Molecular Moderators of Human Social Behavior. Neurosci Biobehav Rev. 2020 Aug;115:251-272. doi: 10.1016/j.neubiorev.2020.04.013. Epub 2020 Apr 28. PMID: 32360414.

14: Marchetta P, Möhrle D, Eckert P, Reimann K, Wolter S, Tolone A, Lang I, Wolters M, Feil R, Engel J, Paquet-Durand F, Kuhn M, Knipper M, Rüttiger L. Guanylyl Cyclase A/cGMP Signaling Slows Hidden, Age- and Acoustic Trauma-Induced Hearing Loss. Front Aging Neurosci. 2020 Apr 9;12:83. doi: 10.3389/fnagi.2020.00083. PMID: 32327991; PMCID: PMC7160671.

15: Karanam G, Arumugam MK. Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr). Mol Biol Rep. 2020 May;47(5):3347-3359. doi: 10.1007/s11033-020-05407-5. Epub 2020 Apr 4. PMID: 32248385.

16: Guo YS, Xu XF, Li N, Sun N, Duan LF. [Gene expression profiles in normal human prostate epithelial cells exposed to low-dose cadmium: A bioinformatics analysis]. Zhonghua Nan Ke Xue. 2019 Feb;25(2):103-109. Chinese. PMID: 32216194.

17: Shuto S. [Medicinal Chemical Studies Based on the Theoretical Design of Bioactive Compounds]. Yakugaku Zasshi. 2020;140(3):329-344. Japanese. doi: 10.1248/yakushi.19-00208. PMID: 32115550.

18: Ishiwata-Endo H, Kato J, Stevens LA, Moss J. ARH1 in Health and Disease. Cancers (Basel). 2020 Feb 19;12(2):479. doi: 10.3390/cancers12020479. PMID: 32092898; PMCID: PMC7072381.

19: Mahmuda NA, Yokoyama S, Munesue T, Hayashi K, Yagi K, Tsuji C, Higashida H. One Single Nucleotide Polymorphism of the TRPM2 Channel Gene Identified as a Risk Factor in Bipolar Disorder Associates with Autism Spectrum Disorder in a Japanese Population. Diseases. 2020 Feb 7;8(1):4. doi: 10.3390/diseases8010004. PMID: 32046066; PMCID: PMC7151227.

20: Joe Y, Chen Y, Park J, Kim HJ, Rah SY, Ryu J, Cho GJ, Choi HS, Ryter SW, Park JW, Kim UH, Chung HT. Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis. Cell Rep. 2020 Jan 28;30(4):1063-1076.e5. doi: 10.1016/j.celrep.2019.12.090. PMID: 31995750.